Design Therapeutics Q3 Earnings Preview: Revenue Estimate at 0
Design Therapeutics is scheduled to report Q3'26 results on November 11. Revenue is estimated at 0 USD and EPS at (0.34) USD; the report time is unspecified.
DSGN (Design Therapeutics, Inc.) is set to announce its Q3'26 results on November 11, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.34) USD. Learn more details at DSGN F…